Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 13 | $7,907,425 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Feb 2025 18:00 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Feb 2025 | Sale | 1,352 | 116.8487 | 157,979 | D |
| 14 Feb 2025 18:00 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Feb 2025 | Sale | 1,206 | 116.8688 | 140,944 | D |
| 12 Feb 2025 18:41 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 10 Feb 2025 | Sale | 980 | 118.274 | 115,909 | D |
| 04 Feb 2025 17:31 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 31 Jan 2025 | Sale | 1,283 | 152.8728 | 196,136 | D |
| 15 Aug 2024 17:12 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Aug 2024 | Sale | 14,100 | 150.3792 | 2,120,347 | D |
| 18 Jul 2024 16:45 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 16 Jul 2024 | Sale | 900 | 150.0411 | 135,037 | D |
| 16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 15 May 2024 | Sale | 15,000 | 140.2406 | 2,103,609 | D |
| 16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 14 May 2024 | Sale | 15,000 | 135.6551 | 2,034,826 | D |
| 15 Feb 2024 17:27 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Feb 2024 | Sale | 1,352 | 132.8488 | 179,612 | D |
| 08 Feb 2024 19:12 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 06 Feb 2024 | Sale | 1,280 | 142.1878 | 182,000 | D |
| 08 Feb 2024 19:12 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 08 Feb 2024 | Sale | 980 | 134.2135 | 131,529 | D |
| 02 Feb 2024 19:00 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 31 Jan 2024 | Sale | 1,283 | 140.7161 | 180,539 | D |
| 23 Aug 2023 19:58 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 21 Aug 2023 | Sale | 2,132 | 107.3914 | 228,958 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)